Studies in the Area of Breast Cancer Reported from University of Texas Southwestern Medical Center (Prmt5 Is an Actionable Therapeutic Target In Cdk4/6 Inhibitor-resistant Er Plus /rb-deficient Breast Cancer)

Press/Media

Period	2 Jul 2024

Media coverage

Title	Studies in the Area of Breast Cancer Reported from University of Texas Southwestern Medical Center (Prmt5 Is an Actionable Therapeutic Target In Cdk4/6 Inhibitor-resistant Er Plus /rb-deficient Breast Cancer)
Media name/outlet	Gene Therapy Daily News
Country/Territory	United States
Date	2/07/24
Persons	Lei Guo